Literature DB >> 18261150

The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.

Axel Haferkamp1, Maria Pritsch, Jens Bedke, Nina Wagener, Jesco Pfitzenmaier, Stephan Buse, Markus Hohenfellner.   

Abstract

OBJECTIVE: To assess whether under- or overweight at the time of surgery has any effect on the survival of the patients with renal cell carcinoma (RCC), as obesity increases the risk of developing RCC. PATIENTS AND METHODS: We prospectively evaluated 780 patients who had nephrectomy for RCC between 1990 and 2005. We used uni- and multivariate Cox proportional hazards models to assess the effect of body mass index (BMI), tumour stage, Fuhrman grade, age, sex, histological type and performance status on cancer-specific survival (CSS). Patients were grouped according to BMI (in kg/m(2)), as underweight (<18.5), normal (18.5-<25), overweight (25-<30) and obese (>or=30).
RESULTS: The median (range) follow-up was 5.3 (0.5-15.4) years, the patients being followed until June 2006; 254 patients died during the follow-up. Multivariate analyses of all patients showed that tumour stage, Fuhrman grade, Karnofsky performance status, age, sex and BMI were independent prognostic factors for CSS. While underweight patients had a significantly worse prognosis than those of normal weight, overweight or obese patients had a similar outcome to that of patients of normal weight. In a subgroup analyses including patients with localized RCC only, there was a strong tendency to less aggressive disease in the overweight group (P = 0.081).
CONCLUSIONS: Being underweight is an unfavourable and new risk factor for CSS in patients with RCC treated by nephrectomy. Although not significant, there seems to be a limited favourable prognostic effect of overweight on CSS in patients with localized RCC.

Entities:  

Mesh:

Year:  2008        PMID: 18261150     DOI: 10.1111/j.1464-410X.2007.07375.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

1.  The value of complementing administrative data with abstracted information on smoking and obesity: A study in kidney cancer.

Authors:  Madhur Nayan; Robert J Hamilton; Antonio Finelli; Peter C Austin; Girish S Kulkarni; David N Juurlink
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

2.  [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].

Authors:  S Waalkes; H Eggers; J Rustemeier; G Wegener; F Jentzmik; M Schrader; R Hofmann; M A Kuczyk; A J Schrader
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

3.  Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy.

Authors:  Amit K Mathur; Amir A Ghaferi; Kristen Sell; Christopher J Sonnenday; Michael J Englesbe; Theodore H Welling
Journal:  J Gastrointest Surg       Date:  2010-02-06       Impact factor: 3.452

Review 4.  Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox.

Authors:  M Bagheri; J R Speakman; F Shemirani; K Djafarian
Journal:  Int J Obes (Lond)       Date:  2016-09-30       Impact factor: 5.095

5.  Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma.

Authors:  Andres Jan Schrader; Julia Rustemeier; Jan Christoph Rustemeier; Nina Timmesfeld; Zoltan Varga; Axel Hegele; Peter Jochen Olbert; Rainer Hofmann
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-20       Impact factor: 4.553

6.  Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis.

Authors:  Jiao Zhang; Qiang Chen; Zhan-Ming Li; Xu-Dong Xu; Ai-Fang Song; Li-Shun Wang
Journal:  Oncotarget       Date:  2018-01-12

7.  Influence of body mass index, smoking, and blood pressure on survival of patients with surgically-treated, low stage renal cell carcinoma: a 14-year retrospective cohort study.

Authors:  Bumsoo Park; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han Yong Choi; Hyun Moo Lee
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

Review 8.  Renal cell carcinoma: links and risks.

Authors:  Reena Kabaria; Zachary Klaassen; Martha K Terris
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-03-07

9.  The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Xiaoxiang Rong; Fang Wei; Qian Geng; Jian Ruan; Hongfen Shen; Aimin Li; Rongcheng Luo
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

10.  Impact of body mass index on clinicopathological outcomes in patients with renal cell carcinoma without anorexia-cachexia syndrome.

Authors:  Daisuke Watanabe; Akio Horiguchi; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Keiichi Ito; Tomohiko Asano
Journal:  Mol Clin Oncol       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.